All News #Library
Others
Alphyn Begins CLEAR-AD1 Phase 2b Trial for Atopic Dermatitis
12 May 2025 //
PR NEWSWIRE
Alphyn Receives Patent Allowance For Zabalafin Hydrogel
21 Aug 2024 //
PR NEWSWIRE
Alphyn Announces Positive Results from Phase 2a Trial in Atopic Dermatitis
07 Mar 2024 //
PR NEWSWIRE

Market Place
Sourcing Support